TA

Tafseer Ahmed

Director Director DIN 07731333
DIN 07731333 First appointment Mar 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2017
Shareholding value •••• Premium profile

About Tafseer Ahmed

Data last updated:

Tafseer Ahmed was a Director at Dee Pharma Private Limited (2021–2024) and Director at Caventis Pharma Private Limited (2017–2018). The companies operate in Healthcare and Pharma.

DIN 07731333
Primary Designation Director
Industry Healthcare
First Appointment 30 Mar 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dee Pharma Private Limited U74999DL2021PTC383699
Director14 Jul 20212021Active
Caventis Pharma Private Limited U51909DL2012PTC240513
Director30 Mar 20172012₹4.88 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dee Pharma Private Limited
Caventis Pharma Private Limited
Premium access

Shareholding and investment profile for Tafseer Ahmed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tafseer Ahmed

Tafseer Ahmed was first appointed on 30 Mar 2017 as Director at Caventis Pharma Private Limited. The most recent appointment on record is 14 Jul 2021 at Dee Pharma Private Limited.

Tafseer Ahmed held 2 earlier board appointments: Dee Pharma Private Limited (Director, 14 Jul 2021 to 29 Nov 2024); Caventis Pharma Private Limited (Director, 30 Mar 2017 to 29 May 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available